351. Targeting Neutrophils for Enhanced Cancer Theranostics
- Author
-
Zhantong Wang, Orit Jacobson, Ying Ma, Maosheng Wang, Longguang Tang, Weijing Yang, Ling Li, Wenpei Fan, Fei Kang, Chunming Huang, Xiaoyuan Chen, Zijian Zhou, Zhiqiang Yu, and Qingchun Mu
- Subjects
Serotonin ,Materials science ,Theranostic Nanomedicine ,Neutrophils ,medicine.medical_treatment ,Photodynamic therapy ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Metastasis ,Cell Line, Tumor ,Neoplasms ,medicine ,Tumor Microenvironment ,Humans ,Hydroxyurea ,General Materials Science ,Molecular Targeted Therapy ,Tumor microenvironment ,Photosensitizing Agents ,biology ,Mechanical Engineering ,Zileuton ,021001 nanoscience & nanotechnology ,medicine.disease ,Primary tumor ,0104 chemical sciences ,Drug Liberation ,Mechanics of Materials ,Myeloperoxidase ,Drug Design ,biology.protein ,Cancer research ,Nanomedicine ,Nanoparticles ,0210 nano-technology ,medicine.drug - Abstract
Improving tumor accumulation and delivery efficiency is an important goal of nanomedicine. Neutrophils play a vital role in both chemically mediating inflammatory response through myeloperoxidase (MPO) and biologically promoting metastasis during inflammation triggered by the primary tumor or environmental stimuli. Herein, a novel theranostic nanomedicine that targets both the chemical and biological functions of neutrophils in tumor is designed, facilitating the enhanced retention and sustained release of drug cargos for improved cancer theranostics. 5-hydroxytryptamine (5-HT) is equipped onto nanoparticles (NPs) loaded with photosensitizers and Zileuton (a leukotriene inhibitor) to obtain MPO and neutrophil targeting NPs, denoted as HZ-5 NPs. The MPO targeting property of 5-HT modified NPs is confirmed by noninvasive positron emission tomography imaging studies. Furthermore, photodynamic therapy is used to initiate the inflammatory response which further mediated the accumulation and retention of neutrophil targeting NPs in a breast cancer model. This design renders a greatly improved theranostic nanomedicine for efficient tumor suppression, and more importantly, inhibition of neutrophil-mediated lung metastasis via the sustained release of Zileuton. This work presents a novel strategy of targeting neutrophils for improved tumor theranostics, which may open up new avenues in designing nanomedicine through exploiting the tumor microenvironment.
- Published
- 2020